Back to Search
ASHLYN KAMIN, PH.D.
PH.D.
Other Specialist/Technologist
NPI: 1760332258Individual
Specialties, Licenses & Credentials
Research & Publications (5)
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
PMID 17610993·J Am Acad Dermatol·2007
3-trial
[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
PMID 16033477·J Dtsch Dermatol Ges·2005
4-observational
Imiquimod in the treatment of extensive recurrent lentigo maligna.
PMID 15692515·J Am Acad Dermatol·2005
5-case
Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
PMID 15459547·Dermatology·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1715A N 45TH ST
SEATTLE, WA 98103 - Phone
- (419) 651-8959
Quick Facts
- NPI
- 1760332258
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile